Yellow Fever Vaccination in an Individual with Confirmed Egg Protein Allergy: A Case Report [0.03%]
一位确诊对鸡蛋蛋白过敏的患者接种黄热病疫苗1例报告
Nelly Otte,Amir Maleki Kahaki,Gerda Wurpts et al.
Nelly Otte et al.
Background: Yellow fever vaccination is recommended for travelers visiting endemic regions in South America and Africa. The live-attenuated vaccine (Stamaril®, Sanofi Pasteur) is produced in embryonated chicken eggs and ...
Case Reports
Vaccines. 2026 Jul 10;14(7):606. DOI:10.3390/vaccines14070606 2026
Influenza Vaccination Willingness, Uptake, and Behavioral Drivers Among Adults Aged ≥60 Years in Henan Province: A BeSD-Based Survey with Registry Follow-Up [0.03%]
河南省60岁及以上成人流感疫苗接种意愿、接受度及行为驱动因素的BeSD调查与注册随访研究
Jun Li,Xinyang Li,Kaichao Yang et al.
Jun Li et al.
Objectives: To identify factors influencing influenza vaccination willingness and uptake among adults aged ≥60 years in Henan Province and to evaluate the effect of a brief educational intervention on vaccination willing...
Evaluating Memory B Cell Cross-Reactivity Between Ancestral and Future SARS-CoV-2 Variants-Evidence for Original Antigenic Sin [0.03%]
评估祖先和未来SARS-CoV-2变异株记忆B细胞交叉反应性——原始抗原则的证据
Lingling Yao,Zoltán Megyesi,Paul V Lehmann et al.
Lingling Yao et al.
Background: Despite the circulation of evolutionarily related cold-causing coronaviruses (CCCs) in the pre-COVID era, most individuals lacked pre-existing serum IgG and/or class-switched memory B cell (Bmem) reactivity for the SARS-CoV-2 Sp...
The Willingness of Healthcare Workers in Makkah, Saudi Arabia, to Be Vaccinated Against Monkeypox and Their Knowledge About Monkeypox: A Cross-Sectional Study [0.03%]
沙特麦加医务人员接种猴痘疫苗的意愿及其对猴痘的知识：一项横断面研究
Khulud A Alhazmi,Karem Ibrahem,Ahmad M Alharbi et al.
Khulud A Alhazmi et al.
Background: Monkeypox (MP) is an emerging disease with the capacity for worldwide dissemination, endangering all nations. Healthcare workers (HCWs) frequently act as the initial point of contact for MP patients; therefore, evaluating their ...
Safety and Immunogenicity of the BNT162b2 COVID-19 Vaccine in Immunocompromised Participants 2 Years and Older: Results of an Open-Label Phase 2b Study [0.03%]
针对免疫功能低下者接种BNT162b2新冠疫苗的安全性与免疫原性：一项开放标签二期临床试验结果
Alpana Waghmare,Rucha Dadhe,Robin Kobbe et al.
Alpana Waghmare et al.
Background: The BNT162b2 vaccine is safe and effective for COVID-19 prevention. BNT162b2 safety and immunogenicity have been evaluated in immunocompromised individuals in real-world observational studies, particularly in pediatric populatio...
Parental Vaccine Hesitancy in the Post-COVID-19 Era: Results from a Cross-Sectional Survey in the United States, 2025 [0.03%]
后新冠肺炎时代美国家长疫苗犹豫现状：2025年横断面调查结果
Syeda Sharmin Duza,Christine Crudo Blackburn,Mayra Rico et al.
Syeda Sharmin Duza et al.
Background/Objectives: Vaccine hesitancy has long been recognized to pose a significant barrier to achieving optimal immunization coverage and as a leading public health threat. However, much of the existing research on parental hesitancy t...
Evaluating Vaccination Coverage and Willingness to Participate in Immunization Programs Among People Living in Prison: A Cross-Sectional Survey in Italy [0.03%]
意大利一项关于囚犯中的疫苗接种覆盖率及参与免疫项目意愿的横断面调查研究
Giovanna Paduano,Vincenza Sansone,Vincenzo Aiello et al.
Giovanna Paduano et al.
Background/objectives: People living in prison are at increased risk of communicable diseases due to overcrowding and suboptimal living conditions. This study aimed to estimate the uptake of recommended vaccinations among...
Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions [0.03%]
肿瘤治疗性疫苗的研究：机制、临床进展和未来方向
Kendra Wilson,Jesus Salvador Flores Banda,Sanjana Bukkapatnam et al.
Kendra Wilson et al.
Therapeutic cancer vaccines have emerged as a promising approach in cancer immunotherapy, aiming to stimulate the immune system to recognize and eliminate malignant cells. Despite this potential, clinical efficacy has remained variable acro...
Mapping Human Clinical Evidence for Chikungunya Vaccines: A Scoping Review of Immunogenicity, Durability, and Safety [0.03%]
人类粘液病疫苗临床证据的人类地图：免疫原性、持久性和安全性的综合评价综述
Shan Wu,Jiachen Wu,Yiu-Wing Kam
Shan Wu
Two chikungunya (CHIKV) vaccines have now been licensed, but the human clinical evidence base remains fragmented across vaccine platforms, populations, follow-up periods, and safety settings, complicating product-specific interpretation of ...
Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges [0.03%]
penile癌的疫苗治疗：证据、机遇与挑战
Firas Hatoum,Ricardo Nehme,Adnan Fazili et al.
Firas Hatoum et al.
Penile squamous cell carcinoma (PSCC) is a rare malignancy with limited therapeutic options in advanced and recurrent diseases. Advanced PSCC is typically managed with multimodal therapy, including neoadjuvant chemotherapy or chemoradiation...